Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ChemCodes Announces Agreement with Wyeth.


Business Editors & Health/Medical Writers

BIOWIRE2K

RESEARCH TRIANGLE PARK Research Triangle Park, research, business, medical, and educational complex situated in central North Carolina. It has an area of 6,900 acres (2,795 hectares) and is 8 × 2 mi (13 × 3 km) in size. Named for the triangle formed by Duke Univ. , N.C.--(BUSINESS WIRE)--Jan. 29, 2003

ChemCodes today announced an agreement with Wyeth (NYSE NYSE

See: New York Stock Exchange
:WYE) to apply the ChemCodes proprietary chemistry platform to synthesize To create a whole or complete unit from parts or components. See synthesis.  compounds for Wyeth. Financial terms of the agreement were not disclosed.

ChemCodes will engage its medicinal chemistry Medicinal or pharmaceutical chemistry is a scientific discipline at the intersection of chemistry and pharmacology involved with designing, synthesizing and developing pharmaceutical drugs.  platform that includes high throughput chemical reactivity mapping, experimental design, experimental tracking, chemoinformatics, data analysis tools and compound delivery to synthesize certain compounds as requested by Wyeth. This evaluation should allow Wyeth scientists to explore diverse chemical reaction paths and to identify conditions to produce research compounds of interest quickly and efficiently supported by comprehensive mapping and analytical data.

"We are delighted to work with Wyeth to complement their chemistry efforts in advancing these projects," said John Didsbury, Ph.D., President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of ChemCodes. "Following on from our research agreement with Roche in October and this agreement with Wyeth, we are on track to achieve our strategic objectives for 2003."

About ChemCodes Inc.

ChemCodes is a chemistry-driven drug discovery company that is focused on R&D collaborations with pharmaceutical and biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
. ChemCodes is using its proprietary high throughput chemistry platform to enable its collaborators to develop new pharmaceutical compounds with improved medicinal properties Many plants have traditional medical uses. Ethnobotanists and pharmacognacists catalog and study these plants and uses. This is a list of some of the more common medicinal properties that are ascribed to plants.  in a process that reduces drug discovery cycle times and utilizes fewer resources.

ChemCodes was founded in June of 1999 based on a proprietary early-stage technology that was licensed from GlaxoSmithKline and developed into an integrated platform over the past two and a half years. The Company's headquarters are in Durham, NC. ChemCodes is backed by a syndicate of top tier venture funds that is comprised of: Intersouth Partners of Durham, NC, Noro-Moseley Partners of Atlanta, GA, Emerging Technology Partners of Rockville, MD and Tri-State Investment Group of Durham, NC. More information can be found at the ChemCodes website www.chemcodes.com.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 29, 2003
Words:308
Previous Article:Airgas Appoints Harold Edwards As President of Puritan Medical Products.
Next Article:RELM Wireless Receives U.S. Forest Service Order Totaling Approximately $900,000.



Related Articles
Andrew Wyeth: Close Friends.
Norplant: no problem ... except that it's off the market. (FYI).
BRIEFCASE INTERSTATE JET SET TO FLY L.A.-N.Y.
When Nureyev stood still: more than 25 years after Rudolf Nureyev posed for artist Jamie Wyeth, the portraits of the great gay dancer still...
PROFITS OF DRUG-MAKER WYETH INCREASE 50%.
The rise and fall of hormone therapy: what began decades ago with promises of eternal youth for women ended last year with troubling research...
Supreme Court lets Third Circuit ruling on fen-phen evidence stand.
Wyeth's comeback kid: Robert Essner guides the pharma giant back from the fen-phen brink.
On the threshold of illness and emotional isolation.
Wyeth.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles